Astrocyte Pharmaceuticals Patents – Insights & Stats (Updated 2023)

Astrocyte Pharmaceuticals has a total of 49 patents globally, out of which 12 have been granted. Of these 49 patents, more than 89% patents are active. The United States of America is where Astrocyte Pharmaceuticals has filed the maximum number of patents, followed by Japan, South Korea, China and Israel. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Astrocyte Pharmaceuticals.

Astrocyte Pharmaceuticals was founded in 2014. Astrocyte Pharmaceuticals is a clinical-stage therapeutic discovery and development firm focused to improving the rehabilitation and well-being of brain injury patients. Astrocyte is dedicated to developing ground-breaking therapeutic agents for the treatment of brain injury caused by stroke, traumatic brain injury (TBI), concussions and neurodegenerative diseases like Alzheimer’s disease.

Do read about some of the most popular patents of Astrocyte Pharmaceuticals which have been covered by us in this article and also you can find Astrocyte Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Astrocyte Pharmaceuticals patent portfolio.

How many patents does Astrocyte Pharmaceuticals have?

Astrocyte Pharmaceuticals has a total of 49 patents globally. These patents belong to 5 unique patent families. Out of 49 patents, 44 patents are active.

How Many Patents did Astrocyte Pharmaceuticals File Every Year?

Astrocyte Pharmaceuticals Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAstrocyte Pharmaceuticals Applications FiledAstrocyte Pharmaceuticals Patents Granted
202312
202256
202151
202011
2019191
20183
2017151

How many Astrocyte Pharmaceuticals patents are Alive/Dead?

Worldwide Patents

Astrocyte Pharmaceuticals Patent Portfolio

How Many Patents did Astrocyte Pharmaceuticals File in Different Countries?

Astrocyte Pharmaceuticals Worldwide Patent Filing

Countries in which Astrocyte Pharmaceuticals Filed Patents

CountryPatent
United States of America9
Japan4
Korea (South)4
China4
Israel4
Europe3
Hong Kong (S.A.R.)3
Australia3
Canada3
Brazil2
South Africa2
Mexico2
India1

Where are Research Centers of Astrocyte Pharmaceuticals   Patents Located?

The Research Center for Astrocyte Pharmaceuticals is the United States of America.

Best Astrocyte Pharmaceuticals Patent

US9789131B1 is the most popular patent in the Astrocyte Pharmaceuticals portfolio. It has received 12 citations so far from companies like Primetime Life Sciences, Llc.

What Percentage of Astrocyte Pharmaceuticals US Patent Applications Were Granted?

Astrocyte Pharmaceuticals (Excluding its subsidiaries) has filed 8 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 6 have been granted leading to a grant rate of 100%.

Below are the key stats of Enterin patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Astrocyte Pharmaceuticals?

Law FirmTotal ApplicationsSuccess Rate
Dechert Llp8100%

List of Astrocyte Pharmaceuticals patents

Astrocyte Pharmaceuticals PatentsTitle
US11484545B2Compounds And Methods For Treating Neurological And Cardiovascular Conditions
US11324769B2Polymorphic Compounds And Uses Thereof
US10953031B2Compounds And Methods For Treating Neurological And Cardiovascular Conditions
US10765693B2Polymorphic Compounds And Uses Thereof
US10265338B2Compounds And Methods For Treating Neurological And Cardiovascular Conditions
US9789131B1Compounds And Methods For Treating Neurological And Cardiovascular Conditions
US20230165887A1Compounds And Methods For Treating Neurological And Cardiovascular Conditions
US20220305044A1Compounds And Methods For Treating Neurological And Cardiovascular Conditions
US20210030760A1Compounds And Methods For Treating Addiction And Related Disorders
EP3856741A4Polymorphic Compounds And Uses Thereof
EP3749322A4Compounds And Methods For Treating Addiction And Related Disorders
EP3445368A4Compounds And Methods For Treating Neurological And Cardiovascular Conditions
CN109310695BCompounds And Methods For Treating Neurological And Cardiovascular Conditions
CN114903903ACompounds And Methods For Treating Neurological And Cardiovascular Conditions
CN112930349APolymorphic Compounds And Uses Thereof
CN112218638ACompounds And Methods For Treating Addiction And Related Disorders
WO2023091791A1Methods Of Treating Neurological And Cardiovascular Conditions
CA3113250A1Polymorphic Compounds And Uses Thereof
CA3126600A1Compounds And Methods For Treating Addiction And Related Disorders
CA3020490A1Compounds And Methods For Treating Neurological And Cardiovascular Conditions
JP7311855B2Compounds And Methods For Treating Addiction And Related Disorders
JP7109005B2Compounds And Methods For Treating Neurological And Cardiovascular Conditions
JP2022088642A5Compounds And Methods For Treating Neurological And Cardiovascular Conditions
JP2022502405A5Polymorphic Compounds And Uses Thereof
AU2017254720B2Compounds And Methods For Treating Neurological And Cardiovascular Conditions
AU2023202694A1Compounds And Methods For Treating Neurological And Cardiovascular Conditions
AU2019346585A1Polymorphic Compounds And Uses Thereof
HK40058352APolymorphic Compounds And Uses Thereof
HK40042287ACompounds And Methods For Treating Addiction And Related Disorders
HK40004057ACompounds And Methods For Treating Neurological And Cardiovascular Conditions
MX391725BCompounds And Methods For Treatment Of Neurological And Cardiovascular Conditions.
MX2021003515APolymorphic Compounds And Uses Thereof.
KR102445887B1Compounds And Methods For Treating Neurological And Cardiovascular Conditions
KR1020220132042ACompounds And Methods For Treating Neurological And Cardiovascular Conditions
IL289423ACompounds And Methods For Treating Neurological And Cardiovascular Conditions
KR1020210093864APolymorphic Compounds And Uses Thereof
BR112021005290A2Polymorphic Compounds And Uses Thereof
IL281718APolymorphic Compounds And Uses Thereof
ZA202101883APolymorphic Compounds And Uses Thereof
KR1020200138197ACompounds And Methods For Treating Addiction And Related Disorders
IL276358ACompounds And Methods For Treating Addiction And Related Disorders
BR112018071560A2Compounds And Methods To Treat Neurological And Cardiovascular Conditions
IL262487ACompounds And Methods For Treating Neurological And Cardiovascular Conditions
ZA201806713ACompounds And Methods For Treating Neurological And Cardiovascular Conditions
WO2022232810A1Purine Nucleosides, Their Intermediates, And Methods Of Preparation Thereof
WO2020069068A9Polymorphic Compounds And Uses Thereof
WO2019157317A1Compounds And Methods For Treating Addiction And Related Disorders
WO2017185061A1Compounds And Methods For Treating Neurological And Cardiovascular Conditions
IN201817040537ACompounds And Methods For Treating Neurological And Cardiovascular Conditions

What are Astrocyte Pharmaceuticals key innovation segments?

What Technologies are Covered by Astrocyte Pharmaceuticals?

The chart below distributes patents filed by Astrocyte Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Astrocyte Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Astrocyte Pharmaceuticals search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Astrocyte Pharmaceuticals?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.